vietnamese crab exporter
Commercial Content

How twin brothers turned a failed telehealth startup into Bask Health

Emma Clapp

It was a naive play, but a hyper-focused one. The twin brothers, native New Yorkers with backgrounds in e-commerce and biotech investment banking, decided to launch a direct-to-consumer telemedicine platform selling eyelash-growth serum. They sourced capital from a former colleague of Elias’s and spent nine grueling months trying to build the infrastructure to prescribe and sell the drug online.

It was a disaster. They couldn’t acquire customers, they bled cash trying to piece together pharmacy and physician networks, and they kept hitting a brick wall when Google and Facebook blocked them from advertising prescription products.

They ran out of money. They shut the company down. They owed their colleague his investment back.

An unexpected opportunity

But as the brothers debated retreating to their old careers, something strange happened. Their consumer website sat dormant, but according to the brothers, the inbox started filling up. Other founders weren’t looking to buy eyelash serum; they were looking to pay for the operational blueprint the brothers had just figured out. They wanted to know how the brothers had built a secure patient intake, routed prescriptions, and managed compliance. They wanted consulting services to launch their own direct-to-consumer telehealth brands.

That dormant inbox was the accidental inception of Bask Health, a New York-based startup that now provides back-end software for telehealth businesses.

Rather than consulting, Zachary (CEO) and Elias (President) packaged their infrastructure into a plug-and-play B2B platform. Bask Health acts as a comprehensive software suite that aims to lower barriers to entry in the direct-to-consumer e-prescribing space. According to Bask Health, instead of spending months coding and hundreds of thousands of dollars navigating compliance pipelines, an entrepreneur can log onto Bask Health, select a medication from the marketplace, tap into a network of over 60 pharmacies and 10 doctor groups, customize a patient portal, and launch a compliant telehealth clinic in a matter of days.

Building the platform

Following the pivot, the company quietly raised a $760,000 Seed round in early 2024. While they operate in a highly competitive sector, Bask Health says its focus on making telehealth infrastructure more accessible to independent entrepreneurs has helped drive its growth.

As demand for GLP-1 weight-loss medications surged, the platform attracted founders building telehealth services to meet growing patient demand. According to the company, Bask Health had processed a substantial volume of transactions by March 2026. Today, the company says transaction volume has continued to grow, with millions of patients passing through its systems.

To support that growth, the company has expanded beyond its Wooster Street headquarters in SoHo. Bask Health now employs a global workforce of roughly 150 people, with a heavily distributed engineering and product team spanning from Cairo to Buenos Aires.

Looking beyond the US market

According to Zachary and Elias Dorf, the brothers are considering an expansion into the UK market, a move that would require them to account for different national compliance and pharmacy regulations in their software. But for two founders who started out hawking $5 lemonade in Tribeca and survived a failed telehealth venture, untangling international medical red tape is just another puzzle to solve. They paid the “stupid tax” of building a healthcare company from scratch, so the next wave of founders won’t have to.

This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.